Fig. 3From: Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) studyMean intraocular pressure (IOP) reduction at weeks 6 and 12 in treatment-naïve and previously treated patients. *P < 0.0001, compared with baselineBack to article page